Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil

Overview of attention for article published in Cancer Management and Research, August 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 14,644 followers.

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial-mesenchymal transition and acts synergistically with 5-fluorouracil. https://t.co/lnd8vAeTIf https://t.co/QNru8zSvPr

28 Aug 2018

Reply Repost Favourite

Low-dose eribulin mesylate exerts antitumor effects in #gastriccancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition ... #cancertreatment https://t.co/lwYITFP5Gl https://t.co/mPvz9Mt3mr

16 Aug 2018

Reply Repost Favourite

RT @StomachCancerCa: Characterized by aggressive proliferation, extensive stromal fibrosis, and resulting drug resistance, peritoneal disse…

15 Aug 2018

Reply Repost Favourite

Characterized by aggressive proliferation, extensive stromal fibrosis, and resulting drug resistance, peritoneal dissemination in gastric cancer remains associated with poor prognosis... #stomachcancer #CancerResearch https://t.co/lwYITFxuhL https://t.co/a

15 Aug 2018

Reply Repost Favourite

Dove Medical Press

Article Metrics

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil

About this Attention Score

Mentioned by

Citations

Readers on